Downstream Regulatory Network of MYBL2 Mediating Its Oncogenic Role in Melanoma
The transcription factor MYBL2 is widely expressed in proliferating cells. Aberrant expression of MYBL2 contributes to tumor malignancy and is associated with poor patient prognosis. However, the downstream transcriptional network that mediates its oncogenic properties remains elusive. In the presen...
Main Authors: | Feiliang Zhong, Jia Liu, Chang Gao, Tingting Chen, Bo Li |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-05-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2022.816070/full |
Similar Items
-
Studies of liver tissue identify functional gene regulatory elements associated to gene expression, type 2 diabetes, and other metabolic diseases
by: Marco Cavalli, et al.
Published: (2019-04-01) -
Understanding gene regulatory mechanisms by integrating ChIP-seq and RNA-seq data: statistical solutions to biological problems
by: Claudia eAngelini, et al.
Published: (2014-09-01) -
A MAPK/miR-29 Axis Suppresses Melanoma by Targeting MAFG and MYBL2
by: Olga Vera, et al.
Published: (2021-03-01) -
Protocol for generating customizable and reproducible plots of sequencing coverage data using the seqNdisplayR package
by: Søren Lykke-Andersen, et al.
Published: (2024-06-01) -
Differentially CTCF-Binding Sites in Cattle Rumen Tissue during Weaning
by: Clarissa Boschiero, et al.
Published: (2022-08-01)